Several factors influence poor prognosis in the young subgroup, such as higher tumour grade at diagnosis, high tumour proliferation, increased expression of HER-2 (ERB-B2) and reduced expression of both estrogen (ER) and progesterone receptor (PR) [7]. The gene discussed is PGR; the disease is neoplasm.